simply click here to claim your deal and get access to all exclusive Business Insider PRIME content.The French pharma giant plans to use its prior research from the 2002-2003 SARS outbreak to speed up the development of a coronavirus vaccine.
The French pharma giant has begun researching a vaccine to counteract the ongoing coronavirus outbreak and believes it has a head start on speedy development. Sanofi is building off of prior vaccine research on the 2002-2003 outbreak of severe acute respiratory syndrome, or SARS. The company plans to test that vaccine candidate against the virus that causes the disease known as COVID-19.
. Some are developing vaccines from scratch using info about the virus's genetic code. Others are testing existing drugs as near-term treatment options. The French pharma giant also anticipates speedy development because there is already an approved flu vaccine that uses the same manufacturing platform. Sanofi's Loew said this large-scale manufacturing is a key advantage for Sanofi in being able to quickly ramp up production of doses in a short time.
Medicine already developed. Contact-
United Kingdom United Kingdom Latest News, United Kingdom United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: CNBC - 🏆 12. / 72 Read more »